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ABSTRACT 
 
Majidi, Nasrin. M.S., Department of Biological Sciences, Microbiology and Immunology 
Program, Wright State University, 2009. A potential strategy to maintain HSV-1 in a 
latent state: use of immunoregulatory peptide mimetics. 
 
                  This study reviews the role of interferon-gamma (IFN-γ) in HSV-1 latency. CD8+ T 
cells inhibit the reactivation of HSV-1 in trigeminal ganglia (TG) by production of IFN-γ. 
Although CD8+ T cells include all the cytotoxic apparatus for cytotoxicity, latently 
infected neuronal cells are not killed by CD8+ T cells. The CD94-NKG2a molecule on 
CD8+ T cells, binds to Qa-1
b 
(a MHC class I like molecule) present on neuronal cell to 
inhibit CD8+ T cells cytotoxicity. 
        Other studies have also determined that the IFN-γ peptide mimetic 95-132 inhibits 
HSV-1 replication in the same way as IFN-γ in infected cells. IFN-γ mimetic peptide binds 
to intracellular domain of interferon gamma receptor-1 (IFNGR-1) and initiates IFN-γ 
signal transduction to the nucleus for gene activation. IFN-γ  mimetic also is more active 
than IFN-γ in gamma activated sequences (GAS) promoter. 
        Epithelial cells such as keratinocytes are the major target cell for HSV-1 replication. 
In a murine keratinocyte cell line (HEL-30), suppressor of cytokine signaling-1 (SOCS-1) 
prevents the antiviral activity of IFN-γ by inhibition of the JAK/STAT signaling pathway. 
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ACRONYMS 
 
α-TIF = α-trans-inducing factor 
CD94 = inhibitory molecule 
DTH = delayed type hypersensivity 
E gene = early gene 
EAE = experimental allergic encephalomyelitis 
ELISA = enzyme linked immune sorbent assay 
Foxp = forkhed/winged helix transcription factor 
GAS = IFN-γ-activated sequence 
HSV-1 = herpes simplex virus type-1 
ICP0 = infected cell protein null  
ICP4 = infected cell protein 4 
IRF = IFN regulatory factor 
IFNGR = IFN-γ receptor 
IE gene = immediate early gene 
IP-10 = IFN-γ-inducible protein 10 
IMPs = importins 
JAK = janus kinase 
L gene = late gene 
LAT = latency associate transcripts 
Mig = monokine induced by IFN-γ 
MBP = myelin basic protein 
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 NO = nitric oxaide 
NLS = nuclear localization sequence 
NKG2a = NK receptor subfamily G2a 
NK cell = natural killer cell 
p-STAT1α = phosphorylated-STAT1α 
PI = post inoculation 
Qa-1
b 
= a MHC class I like molecule 
RT = reverse transcriptase  
SOCS = suppressor of cytokine signaling 
STAT = signal transduction and transcription  
TG = trigeminal ganglion 
Tkip = tyrosine kinase inhibitory peptide 
Treg cells = T regulatory cells 
TNF = tumor necrosis factor 
TLR = toll like receptor 
TGF-β1 = transforming growth factor β1 
vhs protein = virus host shut off protein 
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Objective 
To review the literature concerning HSV-1 latency and potential strategies to prevent   
reactivation of HSV-1 from latency in trigeminal neurons (TGNs). 
I. Herpes simplex virus infection and replication 
      Herpes Simplex Virus 
           Herpes simplex virus is an alpha herpes virus of the herpesviridae family. HSV-1 
causes fever blisters or cold sore infection in humans. Most people get infected when 
exposed to the virus, and recover completely from primary infection. Most primary 
infections with HSV-1are without visible symptoms.  Neuronal cells are susceptible 
targets to be attacked by HSV-1 and virus will remain in them throughout the human’s 
life span. Reactivation of HSV-1 may cause herpes encephalitis. Some stimuli such as 
stress may induce viral gene reactivation. Production and assembly of viral particles 
overcome the body’s immune system and leads to secondary infection (6, 9, and 16).  
   HSV-1 structure 
        Herpes simplex viruses are enveloped viruses. The envelope consists of different 
glycoproteins (gB, gC, gD, gE, gG, gH, gI, gK, gL, gM) which are responsible for 
attachment to the cellular receptors. The inner layer of the virus is the capsid made of 
capsomeres about 100-200 nm in diameter with an icosahedral nucleocapsid. The space 
between the envelope and the capsid is called the tegument. The tegument contains 
proteins and enzymes which are involved in the virus replication (9).  
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Linear double stranded DNA contains three classes of genes: Immediate early (IE) genes, 
early (E) genes, and late (L) genes. Immediate early genes regulate expression of other 
herpes virus genes (9). 
         Infected cell protein null (ICP0) and ICP4 are two products of IE genes. ICP0 (a 
promiscuous transactivator of gene expression that it is required for both efficient 
initiation of lytic infection and reactivation from latency) and ICP4 have an important 
role in the early (E) and the late (L) genes expression. Early genes arrange the stage for 
viral DNA replication and late gene activation. Expression of late genes encodes viral 
structural proteins.  Low-level expression of immediate early (IE) and early (E) viral 
genes during latency inhibits the virus replication which induces a chronic immune 
response. ICP0 and ICP4 could not be expressed in latently infected TGs. Latency 
associate transcript (LAT) with sequence antisense to ICP0 blocks ICP0-mediated virus 
replication and induce latency in neuronal cell. In contrast, expression of ICP0 or ICP4 in 
early stage of infection induces virus replication (lytic infection) in infected cell (2, 9).   
 HSV-1 entry to the host cell 
        As shown in Figure 1, HSV-1 infects host cells by interfering with glycoprotein gB 
or gC, to the cell receptor heparan sulphate.  In the next step, binding of one herpes virus 
entry protein (HveA, HveC and HveB) to the glycoprotein gD causes conformational 
change. This conformational change allows gD to bind to gB or gH-gL dimmer. 
Following this interaction, virus fusion occurs through host cell plasma membrane (9). 
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Svend Ellermann-Erikson. Virol. J, 2005, 2:59 doi: 101186/1743-422x-2-59 
Figure 1. Electron micrograph of HSV-1 structure and glycoproteins involved in adsorption of virus to the 
host cell. 1= Important mediator of HSV-1 entry to the host cells. 2= receptors interaction. 3= membrane 
fusion (Adapted from 9). 
 
HSV-1 replication  
         HSV-1 proteins (α,β,γ) are produced during virus replication. Virus recruits cellular 
RNA polymerase II for its gene transcription. Immediate early (IE) genes express α 
proteins, which then induce early gene expression. Tegument proteins such as α-trans-
inducing factor (α-TIF) initiates immediate early gene transcription. Expression of these 
three gene classes results in assembly of virus particles which bud from the host cell. In 
contrast, induction of latency associate transcripts (LATs) leads the virus toward latency. 
LAT suppress IE genes during HSV-1 primary infection and facilitate latency in neuronal 
cells.  Another tegument protein which has important role in virus replication is virus 
host shut off protein (vhs). This protein shuts off the host cell production machinery and 
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recruits it for its own replication.  Late protein expression forms capsid and receptors on 
the surface of the virus. Assembly of virus particles including genome, core and capsid 
occurs in the nucleus of the cell. The virus envelope is created by budding into the inner 
nuclear membrane of the cell (2, 6, and 9). 
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II. Anti viral host defense 
 Cellular response in primary infection with HSV-1 
        HSV-1 primary infection induces an acute response during the first days of 
infection. Natural killer (NK) cells and macrophages are two major cell groups that 
produce IFNs in early defense against HSV-1 infection.  
        During first few hours macrophages produce cytokines such as IFN type I (IFN-
α/β), TNF, and IL-12. These cytokine products stimulate more macrophages to produce 
reactive oxygen species (ROS) which have a direct antiviral effect. Depletion of these 
cytokines enhances mortality of mice treated with HSV-1. Each cytokine gene expression 
is induced through a particular signaling pathway. For example, signaling of IFNα/β 
gene activation is induced by NF-κB family transcription factors. NF-κB is an 
intracellular transcription factor which interacts with intracellular domain of toll like 
receptors (TLR2, TLR3, and TLR9), IL-1R, and TNFR and transfers the signal to the 
nucleus for IFNα/β gene activation (9). HSV-1 transcripts (i.e. LAT or ICP27) are related 
to cytokine expression in acute infection. Immediately after HSV-1 infection, IE and E 
genes produce their protein.  Each of these proteins could induce cytokine production (2, 
7, and 9). 
          As discussed previously, type I IFN and TNF are secreted immediately after HSV-
1 infection in host cells. A few hours after these are produced, macrophages react with 
the HSV-1 by producing IL-12.  As shown in figure 2, production of IL-12, IL-18, TNF 
and IFNα/β by macrophages will induce IFN-γ production in NK cells. IFN-γ later 
induces macrophages to produce more IFN-α/β, TNF and IL-12. IFNα/β and TNF 
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negatively regulate IL-12 production in macrophages. Nitric oxide (NO) produced by 
macrophages exerts direct anti viral activity. In Figure 2, note that IFN-α and IFN-β may 
have direct effect on HSV-1 infection.  ELISA analysis of TGs infected with HSV-1 also 
demonstrated that IL-2, IL-6, IL-10, and IFN-γ proteins were present in acutely infected 
TGs (7, 9).  
 
Svend Ellermann-Erikson. J viral, 2005, 2:59 doi: 101186/1743-422x-2-59. 
Figure 2. Production of cytokines during HSV infection in macrophages and NK cells (Adapted from 9). 
 
IFN signaling pathway 
                 Interferon plays an important role in the antiviral activity of target cells in HSV-1 
infection. Interferons are produced by different cell types including NK and macrophages 
cells in first line of host defense. IFN-γ produced by CD8+ T cells is effective against 
HSV-1 infection in adaptive immunity. IFN-γ binds to its specific receptors on the target 
cells and stimulates gene transcription. All type I IFNs (IFN-α/β) bind only to 
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IFNAR1/IFNAR2 whereas the Type II (IFN-γ) receptors are composed of two peptide 
chains IFNGR1 and IFNGR2 (23, 24).  IFN-γ signaling begins with interaction of IFN-γ 
with an IFN receptor complex consisting of two IFNGR1molecules and two IFNGR2 
molecules (23).   
       The C-terminus of IFN-γ consists of a nuclear localization sequence (NLS), which 
plays an important role in binding of IFN-γ to IFNGRs. Endocytosis of IFNγ into the cell 
occurs with interaction of IFN-γ NLS domain to IFNGR1. NLS domain also can bind to 
IFNGR1 intracellular domain and induce JAK2 phosphorylation in tyrosine residue (19, 
24).  Autophosphorylation of JAK2 will induce activation and phosphorylation of 
STAT1α. Following this induction, STAT1α transfers signal through mediators such as 
importin-α5 (IMPα5) to the nucleus. Each cytokine has a particular signaling pathway. 
IFNs (type I and II) select their specific pair of janus kinase (JAK) and signal 
transduction and transcription (STAT) group for translocation of the signal to the 
nucleus. For example IFN-α/β receptor complex recruit JAK1/Tyk2 for functioning, 
while IFN-γ employs JAK2/STAT1α for the signaling pathway (5, 9, 19, and 24).   
 
 
 
 
 
 
 
 
 
Figure 3. IFN type I (α, β, κ, ε
(Adapted from Google images)
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, and ω) and IFN  type II (IFN-γ) signaling  pathway. 
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         Based on the role of IFN-γ in the inhibition of HSV-1 that is determined by various 
studies, investigators sought to develop an IFN mimetic peptide which may inhibit HSV-
1 infection in the same manner as IFN-γ (20). Most experiments have demonstrated that 
IFN-γ mimetic is even more active than IFN-γ (22). IFN-γ mimetic peptide consists of N-
terminal and C-terminal units, which the C-terminal consists of nuclear localization 
sequence (NLS) region. C-terminal of IFN-γ  is necessary for IFN-γ mimetic function 
(19). NLS region does not have antiviral activity itself. Lipophilic group are also added to 
IFN-γ C-terminal for cell penetration. C-terminal of IFN-γ binds to intracellular domain 
of receptor while N-terminal binds to extracellular domain (19).  
      Viruses have some strategies to escape from immune response. For example, vaccinia 
virus produces B8R protein (a virulence factor of poxviruses) to evade from the host 
immune response (18). B8R virulence factor which is a homology of extracellular 
domain of IFNGR1 binds to IFN-γ and prevents its interaction with IFNGR1 on the cell 
surface. IFN-γ peptide mimetic is a small peptide with attached lipo- palmitate in C- 
terminal for the cell penetration. This peptide binds to intracellular domain of IFNGR1 
and initiates the IFN-γ signaling path way through phosphorylation of JAK2/STAT1α 
(20, 21).  
SOCS-1 expression suppresses the IFN-γ activity 
          HSV-1  uses suppressor of cytokine signaling (SOCS) proteins to fight on immune 
response. These protein products are inducible when IFN-γ binds to its receptor on the 
cell surface and negatively regulates IFN-γ antiviral activity in HSV-1 infection. The 
SOCS family include 7 members; SOCS1, SOCS2, SOCS3, SOCS4, SOCS5, SOCS6, 
10 
 
and SOCS7.  SOCS has a kinase inhibitory region (KIR) and src homology 2 (SH2) 
domains which are very important in binding of SOCS-1 to JAK2. The binding of KIR 
region to JAK2 tyrosine residue inhibits the autophosphorylation of STAT1α. Inhibition 
of STAT1α autophosphorylation results in IFN-γ signaling path way shut off. Using a 
SOCS mimetic or tyrosine kinase inhibitory peptide (Tkip) in HSV-1 infection showed 
this peptide mimetic is able to bind to tyrosine residue of JAK2 and prevents STAT1α 
phosphorylation in IFN-γ signaling pathway. This observation led the investigators to 
develop a SOCS antagonist that blocks SOCS activity produced by virus. SOCS-1 
peptide antagonist binds to KIR region of SOCS-1 and allows JAK2 phosphorylation and 
subsequently STAT1α phosphorylation and IFN-γ signaling pathway continues (23, 24, 
25, 26, and 27). 
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III. HSV-1 latency 
Cellular interactions in HSV-1 latent infection in Trigeminal Ganglia (TG) 
          After primary infection, HSV-1 persists in neural ganglia throughout human life 
span. During latent state, HSV-1 produces latency associate transcript (LAT) mRNA. 
Immediate early (IE) and early (E) genes expressions are very low. This low level of α 
and β proteins are essential to induce CD8+ T cells activity. CD8+ antigen specific T 
cells with IFN-γ production capacity are the major immune cells in trigeminal ganglia 
(TG). These cells inhibit the viral replication in neuron cells without any cell destruction 
(1, 6). 
         Chemokines such as IP-10 and RANTES are present in Trigeminal Ganglia (TG), 
and recruit other immune cells to defeat active HSV-1infection (12). All these factors 
together overwhelm the virus replication and keep it in a latent state.  The reason that 
neurons are susceptible to HSV-1infection could be the low level expression of MHC 
molecules (1). Neuronal cells with transient expression of MHC class I molecules are 
able to present the virus antigen to CD8+ T cells (1).   
        Cellular immunity including CD8+ Tcells, CD4+ T cells and γ/δ T cells are essential 
to fight HSV-1 infection in TG. CD8+ T cells do not eradicate HSV-1 with their 
cytotoxic effect in neuronal cells. CD8+ T cells also defeat HSV-1by its non lytic 
activation in primary infection. In latent state, neuron cells infected with HSV-1 will not 
be killed by CD8+ T cells, because CD8+ T cells use their nonlytic mechanism only to 
overcome HSV-1 replication in latent state. Although CD8+ T cells contain lytic 
granules, they are not able to kill neuronal cells (1, 6).  
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        This observation guided Suvas (1) and colleagues to ask whether other mechanisms 
such as cellular interaction could be involved in the CD8+ T cells function (1).  For this 
purpose they infected female 6 to 8 weeks old C57Bl/6 (B6) mice with HSV-1. TG were 
removed 28 days after ocular infection and flow cytometry used for cell surface and 
intracellular staining of the neuron nucleus.  Granzym B (induces apoptosis in viral 
infected cells) and perforin (cytolytic protein) were expressed in CD8+ T cells isolated 
from TG. They also examined the expression of NK inhibitory receptors on T-cells. The 
result showed 65% of Ag-specific CD8+ T cells express NKG2a (1).  
        In next experiment the expression of CD94 molecule (inhibitory receptor) on 
CD8+T cells also examined.  NKG2a functions when co-expressed with CD94 on CD8+ 
T cells. Results showed 80% of the CD8+Tcells positive for NKG2a expressed CD94 
molecule. They hypothesized interaction of CD94/NKG2a and Qa-1
b
 (a MHC class I like 
molecule) on neuronal cells may blocks cytolytic activity of CD8+Tcells.Therefore they 
used MC-38 (a colon carcinoma cell) as target cell to show Qa-1
b
 expression. As shown 
in Figure 4a ~ 50% of MC-38 cells were able to express Qa-1
b 
molecule (1). 
       In the next experiment, an immunogenic peptide derived from HSV-1 (SSIEFAR) 
was added in two different concentrations (2.0 and 0.2 µM) to target cells (MC-38 cells) 
that were co-cultured with CD8+ T cells.  This system was used to determine the level of 
cytotoxicity of CD8+ T cells for the HSV-1 peptide. Cells treated with both 
concentrations showed significant cell lysis in the presence of the CD8 + T cells. As 
shown in Figure 4b, blocking of the CD94-NKG2a-Qa1
b
 interaction increased CPE of 
target cells (using anti-Qa-1
b
 Ab). These result demonstrated that, in spite of expression 
of lytic granules in HSV-specific CD8+Tcells for the treated carcinoma cell line, these 
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CD8+ T cells could not destroy the cultured neuronal cells due to CD94-NKG2a-Qa1
b
 
interaction (1). 
  
 
Figure 4. The effect of Qa-1
b
-CD94/NKG2a  interaction blockage on the CD8+ Tcells cytotoxicity. a, 
Using target cells MC-38 (a colon carcinoma cell line) for the expression of Qa-1
b
 molecule. b. The effect 
of anti-Qa-1
b 
on cell lysis (Adapted from 1). 
 
       Co-expression of CD94/NKG2a on HSV-1 CD8+ specific T cells could be induced 
by transforming growth factor β1 (TGF-β1), which is present in TG after HSV-1 
infection. The presence of CD4+CD25+ reg (regulatory) T cells in TG could be a 
possible source of TGF-β1. To determine whether CD4+ CD25+ T reg cells play a role in 
TGF-β1 expression in latent infection of TG, B6 mice were treated (28 days p.i.) with a 
monoclonal antibody  (PC61) to deplete endogenous CD25+T cells. The level of TGF-β1 
protein was decreased in CD4+CD25+ T cells depleted TG culture. This treatment almost 
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completely depleted TGs of CD4+CD25+ T cells. Regulatory CD4+Foxp3+ T cells 
(∼4%), another source of TGF-β, were expressed in the latent TG of such treated animals. 
Therefore CD4+ CD25+ T reg cells may play an important role in induction of CD8+ T 
cells cytotoxicity (1).  
  
Cytokines in latently infected TG models 
                    Ocular infection with HSV-1 results a latent infection in mice. Lymphocytes persist 
in TG producing of cytokines that maintain the virus in non replicating state. If immune 
system was not able to clear HSV-1from the body, virus moves to central nervous system 
and may cause fetal encephalitis (an acute inflammation of brain) (7).                             
          Halford and colleagues (7) hypothesized that the cytokines expression in TG may 
have some effect on fetal encephalitis. They infected ICR mice by corneal inoculation 
with HSV-1 and six to nine days later 4 of 5 mice died with fetal encephalitis. Cytokine 
transcript expression (especially IL-10 and IFN-γ mRNAs) was strongly up-regulated in 
acutely infected TG 5 days post inoculation (PI). RT-PCR detection of LAT RNA was 
used to confirm that TGs were infected with HSV-1. ICP27 is a α gene production which 
is necessary for HSV-1 infection. Therefore the presence or absence of ICP27 mRNA 
would confirm the virus is in latent or active state, respectively in this experiment ICP27 
mRNA was not detected. Thus the replication of virus was inhibited by cytokine 
expression in some way in TG (7).   
        Within TG cytokines such as  TNF-α, IL-6 IFN-γ inhibit HSV-1 reactivation. TNF-α 
is also produced in the innate response against HSV-1 by macrophages and NK cell (8).  
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         To study whether the depletion of this cytokine has any effect on disease severity, 
Minagawa and colleagues (8) examined the effect of neutralizing specific 
proinflammatory cytokines on HSV-1 reactivation from TG explants. They examined the 
effect of TNF depletion in HSV-1 reactivation both in vitro, and in vivo in TNF-knockout 
mice (8). BALB/C mice 5-6 weeks of age were inoculated with HSV-1 in both eyes, and 
after 8 weeks TG removed from mice and added to fresh medium. Samples were taken 
from TG cultures and added to Vero cells to monitor the cytopathic effect (CPE) in vitro. 
As shown in Figure 5, depletion of TNF in the cell culture resulted in virus reactivation, 
which was significant when compared with control. In contrast, adding anti-IL6 had no 
effect on virus reactivation (8).  
         They did the same study in vivo on B6 mice, which are more resistant to HSV-1 
infection than BALB/C mice. B6 TNF knock-out mice were infected with HSV-1 and 
survival percentage monitored. In TNF-knockout mice the survival percentage dropped to 
0-40%. Therefore using TNF-KO mice showed that TNF has an important role in the 
body’s immune system against HSV-1 reactivation in TG (8). 
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Figure 5. The effect of TNF and IL-6 depletion on reactivation of HSV-1. TG explants were depleted from 
IL-6 or TNF using specific antibodies and the HSV-1 reactivation detected (Adapted from 8). 
 
Effect of neutrophils on HSV-1 infection 
           Similar to T lymphocytes and macrophages, which are thought to be the major 
cellular defense against HSV-1 infection, neutrophils also participate indirectly against 
HSV-1 infection. Neutrophils  produce chemokines such as interferon-inducible protein 
10 (IP-10) and monokine induced by IFN-γ (Mig)  that attract  the other immune cells 
(CD4+ and CXCR3+ expressing cells) to the site of infection. Molesworth-Kenyon and 
colleagues (12) hypothesized that neutrophil depletion would have an inhibition effect on 
cellular recruitment to the delayed type hypersensivity (DTH) site. BALB/c mice were 
treated with HSV-1 via right cornea and DTH monitored by ear swelling assay.   
Neutrophils depleted 9 days later by i.p. administration of monoclonal antibody (RB6  
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8C5 Ab) in mice.  On day 10, the mice were challenged in the ear pinna with HSV-1. 
Figure 6 show that mAb RB6 8C5 mice treatment reduced the number of neutrophils at 
the DTH site by 85%. CD4+ and CD8+ T cell recruitment was reduced significantly by 
90% and 70%, respectively. Depletion of neutrophils also resulted in a 73% reduction in 
cells expressing the chemokine receptor CXCR3. Therefore neutrophils synergize with 
the other immune cells such as CD4+, CD8+ T cells in preventing HSV-1 infection. (12). 
 
Figure 6. Depletion of neutrophils, reduced the number of immune cell infiltration to the DTH site. The 
number of infiltrating neutrophils, CD4+Tcells, CD8+ T cells, and CXCR3+ cells determined  by 
immumohistochemical staining using appropriate antibodies and compared with control IgA (Adapted from 
12). 
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IV. Using peptide mimetic for antiviral activity 
Antiviral activity of IFN-γ mimetic peptide 
        NLS domain of IFN-γ interacts with cytoplasmic domain of IFNGR1 and 
phosphorylates JAK2 in tyrosine residue, this autophosphorylation induces STAT1α 
activation. In the next step, the complex (IFN-γ/IFNGR1/JAK2/ STAT1a) associates with 
IMPα5 which later translocates to nucleus to activate gene transcription (22). 
        Fulcher and colleagues (22) hypothesized that the IFN-γ mimetic peptide has the 
same affinity for IMPs as does IFN-γ in signal transduction to the nucleus. They 
synthesized a mIFN-γ peptide mimetic with binding affinity to IMPs (Importins). Using 
ELISA- based binding assay they showed that both IFN-γ and mIFN-γ had affinity to 
IMPs (antibody specific to IMPα-GST). IFN-γ peptide mimetic even had more affinity to 
IMPs compared to control T-ag 111-135-β-gal (22). 
         In the next experiment, they used plamids to transfect of mIFN-γ mimetic and IFN-
γ  which were bound to firefly luciferase to activate GAS promoter. As shown in Figure 
7, mIFN-γ peptide mimetic was more active than IFN-γ in activating the IFN-γ activated 
site (GAS) promoter (by measuring of luciferase activity). These results demonstrated 
that high affinity of IMPα/β for mIFN-γ mimetic leads to activation of GAS promoter 
and gene transcription (22). 
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Figure 7. Use of IFN-γ mimetic or IFN-γ to activate GAS promoter. Plasmids expressing non-secreted IFN-
γ or IFN-γ mimetic peptide were transfected into WISH cells together with a reporter plasmid. Using 200 
ng of IFN-γ and IFN-γ mimetic showed higher GAS promoter activity. 50 ng determined lower activity. In 
both concentrations IFN-γ mimetic was more active than IFN-γ (Adapted from 22). 
 
The effect of vaccinia virus virulence factor B8R on IFN-γ 
         Viruses exert various strategies to escape from host immune responses. IFN-γ has 
an important role in host antiviral activity in various viral infections such as HSV-1 and 
vaccinia virus infections.  B8R protein (a virulence factor and homology of extracellular 
domain of IFNGR1) produced by vaccinia virus binds to IFN-γ  and prevents its 
attachment to extracellular domain of IFNGR1 on target cell. IFN-γ mimetic peptide is a 
small peptide with lipo-palmitate attached to C-terminal for cell penetration. This peptide 
is able to penetrate to the cell and bind to the intracellular domain of IFNGR1 and 
initiates the IFN-γ signaling pathway in vaccinia virus and other viruses such as HSV-
1(18).  
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Ahmed and colleagues (18) hypothesized that a synthesized IFN-γ peptide mimetic which 
binds to intracellular domain of IFNGR1 and induce phosphorylation of JAK/STAT 
mediators may block the B8R activity (18). 
        They synthesized a small IFN-γ  mimetic peptide (mIFN-γ) 95-132 for mice.  C57BL/6 
mice treated with different doses of lipo-mimetic IFN-γ 95-132, non-lipomimetic (lipophilic 
palmitate is absent for cell penetration) and lipo control (NLS is absent for binding to 
intracellular domain of IFNGR1) i.p., and then the mice were challenged with vaccine 
virus with B8R production potential. As shown in Figure 8 mice were completely 
protected with 200 µg, but protection with 50, 15, and 5 µg decreased to 80, 80, and 40%, 
respectively. Mice were not protected with non-lipo mimetic and lipo-control treatment. 
This approach led the investigators to design an IFN-γ mimetic peptide therapy for 
humans infected with vaccinia virus and other viruses (18). 
 
   Figure 8. mIFN-γ 95-132 role in the protection of mice against encephalomycarditis caused by vaccinia 
virus.    Different doses of lipo-mimetic IFN-γ 95-125 were given to C57BL/6 mice (5, 15, 50, 200 µg) and 
then  challenged with vaccinia virus and mice survival percentage followed (Adapted from 18).    
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Tkip negatively regulates cytokine signaling path way  
       IFN-γ binds to its receptor (IFNGR1) on the cell and autophosphorylats JAK2.  
Suppressor of cytokine signaling 1SOCS-1 binds to JAK tyrosine residue and inhibits 
STAT1 autophosphorylation which leads to blockage of IFN-γ signaling pathway (21). 
       The abnormal phosphorylation of JAK tyrosine kinase region also causes 
inflammatory diseases such as experimental allergic encephalomyelitis (EAE) (an animal 
model for multiple sclerosis). To confirm this hypothesis Mujtaba and colleagues (21) 
developed a tyrosine kinase inhibitory peptide (Tkip) which has 12 residues 
(WLVFFVIFYIFYFFR) which bind to the tyrosine kinase residue of JAK2 and makes it 
inaccessible for binding of STAT1α. For this experiment, Tkip and IFN-γ 95-125 peptides 
were synthesized and acute EAE induced in NZW mice. Then lipo-Tkip, lipo-IFN-γ 95-133 
was given to mice i.p. and the severity of disease was monitored. As shown in figure 9, 
Tkip treated mice did not develop acute EAE. In contrast mice treated only with PBS are 
not protected. Therefore using Tkip could be useful to control inflammatory diseases 
such as EAE (21).  
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Figure 9. Treatment of mice with the suppressor of cytokine signaling-1 mimetic peptide, Tkip, prevents 
development of the acute form of EAE. NZW mice were treated with Tkip i.p.  Control mice received PBS. 
All of the BPS mice developed EAE (Adapted from 21). 
 
SOCS-1 KIR and Tkip inhibit IFN-y induced macrophages activity 
       Tkip binds to JAK2 autophosphorylation site and prevents STAT1α binding and 
subsequent phosphrylation (23). The prevention of STAT1α phosphorylation results in 
inhibition of activation of further mediators, and IFN-γ signal transduction path way will 
be halted. Similar to Tkip, SOCS-1 KIR recognizes the JAK2 tyrosine region for its 
function and follows the pathway discussed above. To confirm this hypothesis, Waiboci 
and associates (23) sought to show both SOCS-1-KIR and Tkip bind to JAK2 
autophosphorylation site and prevent binding and autophosphorylation of STAT1a. For 
this purpose, they immobilized SOCS-1-KIR, Tkip, and control peptide on 96-well micro 
titer plates and incubated with JAK2 (1001-1013). Binding assays showed both SOCS1-
KIR and Tkip bound to JAK2 autophosphorylation site (23). In the next experiment, they 
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showed SOCS1-KIR and Tkip inhibited cytokine signaling through blocking of STAT1α 
phosphrylation in murine U937 cells (immunoblot analysis of STAT1α).  Macrophages 
have a key role in antiviral resistance, and are inducible by IFN-γ. The macrophage cell 
line Raw 264.7 was activated by IFN-γ and SOCS1-KIR or Tkip were then used to 
determine if they are able to block nitrite oxide (NO) production by macrophages. Figure 
10 shows both Tkip and SOCS1-KIR inhibited the NO production. The SOCS1 
antagonist may provide a therapeutic strategy for viral infections (23). 
  
 
Figure 10. The role of TKip or SOCS-1 in induction of NO by various concentrations of IFN-γ in 
macrophages. Raw 264.7 macrophages were incubated with different concentration of IFN-γ alone or in the 
presence of either Lipo Tkip, Lipo SOCS1-KIR or control. Nitrite concentration determined using Griess 
reagent (Adapted from 23). 
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IFN signal transduction is inhibited by over expression of SOCS 
         Yokota and colleagues (24) demonstrated that SOCS3, member of SOCS family, 
inhibits IFN-α signal transduction through blocking of JAK/STAT path way in the same 
manner as SOCS-1. They used defective HSV-1 (mutated in tegument proteins UL41 and 
UL13) and wild type (VR3). Human amnion cell line FL was infected with HSV-1 wild 
type (VR3) or defective d41 or d13, and then treated with INF-α to examine the effect of 
SOCS3 on STAT1 phosphorylation. SOCS3 produced by wild type VR3 inhibited the 
phosphrylation of   JAK2 /STAT1. In contrast, mutated strains d41 or d13 could not 
prevent STAT1 phosphorylation completely (24).  
         They also sought to show whether over expression of SOCS3 in FL cell culture has 
the same result. FL cell culture was transfected with the pSOCS3 expression plasmid. 
Shown in Figure 11A is SOCS3 expression in the cultures transfected with pSOCS3 
expression plasmid. After 24 h, transfected cells were treated with IFN-α. Western blot 
showed STAT1 phosphorylation was inhibited in SOCS3 over expressed cells. These 
results determined HSV-1 uses SOCS3 in the same strategies as SOCS1 for its antiviral 
function (24). 
 
Figure 11. IFN signal transduction is inhibited by over expression of SOCS3. Over expression of SOCS3 in 
FL cells with pSOCS3 expression plasmid and then treated them with IFN-α. IFN-α-induced STAT1 
phosphorylation was inhibited in cells transfected with pSOCS3 (Adapted from 24). 
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The role of IFN-γ  anti viral activity in fibroblast (L-929) or Keratinocytes (HEL-30) 
       Epithelial cells such as keratinocytes are the major target cells for HSV-1 replication. 
To determine why HSV-1 targets keratniocyte cell line for its replication, Frey and 
associates (27) considered keratinocyte and fibroblast cell lines for their experiments. As 
discussed before, IFN-γ is an effective cytokine against HSV-1 infection. Therefore, 
induction of this cytokine in the cell infected with HSV-1 would have some benefits to 
protect cell from virus destruction. They treated keratinocytes (HEL-30) and fibroblast 
(L-929) cells with murine IFN-γ or IFN-γ peptide mimetic, and then these cell cultures 
were infected with HSV-1. Two to three days post infection cell survival observed. As 
shown in figure 12 IFN-γ protected fibroblasts cells from HSV-1 infection in 50, 25, 12.5 
and 6.25 concentration, but this protection was abrogated with the same concentration in 
HSV-1 infected keratinocytes (27). 
   
Figure12. The effect of IFN-γ on L929 fibroblasts (a) or HEL-30 keratinocytes (b) infected with HSV-.  
Recombinant murine IFN-γ added to the cultures at the concentration of 12.5 to 50, and cells lysis was 
monitored (Adapted from 27). 
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They hypothesized that the IFN-γ signaling may be obstructed somewhere in the cell 
signaling pathway. They developed a small peptide mimetic of mouse IFN-γ (95-
132).This synthetic mimetic peptide could penetrate the plasma membrane via palmitate 
attached to C-terminal. The mimetic peptide was able to activate JAK/STAT transduction 
pathway in the same manner as IFN-γ (discussed in previous studies). Using mimetic 
IFN-γ peptide in keratinocytes (HEL-30) or fibroblasts (L-929), HSV-1 replication was 
inhibited only in fibroblasts, but not in keratinocytes (27). 
    
Figure13. The effect of IFN-γ mimetic peptide (95-132) on Fibroblasts cells L929 (a) and Keratinocytes 
HEL-30 (b). L929 and HEL-30 treated with IFN-γ mimetic at the indicated concentration. The effect of 
IFN-γ mimetic on L929 and HEL-30 cells determined based on cell survival (Adapted from 27). 
 
 
Since several studies have determined SOCS negatively regulates the IFN-γ activity. Frey 
and colleagues hypothesized that SOCS-1 may inhibits IFN-γ antiviral activity in 
keratinocytes. HEL-30 keratinocytes and L929 fibroblasts were infected with HSV-1 and 
SOCS-1 expression detected by Western blot analysis. As shown in figure 14,   
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keratinocytes (HEL-30 cells) expressed of SOCS-1 mRNA, while infected fibroblast cells 
did not show SOCS-1 mRNA expression. HSV-1 induces SOCS-1 expression in 
keratinocytes (HEL-30 cells), but not in fibroblasts (L929 cells) (27). 
 
        
 
Figure 14. RT –PCR analysis of SOCS-1 mRNA expression in HSV-1 infected fibroblasts    and     
keratinocytes.  HEL-30 and L929 cells were infected with HSV-1. Total RNA      was extracted and used as a 
template for RT-PCR using primers specific for SOCS-1 or GAPDH as a   control (Adapted from 27). 
 
STAT-1α phosphorylated by IFN-γ induction in fibroblasts (L-929) but inhibited in 
keratinocytes (HEL-30) 
They suggested  SOCS1induced by HSV-1in keratinocytes may bind to JAK2 by its KIR 
(kinase inhibitory regeon) and prevents JAK2 phosphrylation and finally blocks the IFN-
γ signal transduction.  To confirm this suggestion, IFN-γ -treated keratinocytes or 
fibroblasts were infected with HSV-1, and  STAT1α phosphorylation detected. As shown 
in Figure15  L-929 cells expressed pSTAT1α phosphorylation, but HEL-30 cells did not. 
This demonstrates that HSV-1 employs SOCS-1 to inhibit HSV-1 antiviral activity in 
keratinocytes but not in fibroblasts (27). 
 
 
 
 
HEL-30
L929 L929
HEL-30
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HSV-1        - - +   
IFNγ - +           +
pSTAT1α
STAT1α
HSV-1       - - +   
IFNγ - +  +
pSTAT1α
STAT1α
 
A.HEL-30 cells                                                     b. L929 cells 
 
 
 
 
 
 
 
 
Figure 15. STAT1α activation by IFN-γ inhibited in HEL-30 cells (a) but not in L929 cells (b). HEL-30 or 
L929 were treated with HSV-1. Some of the infected cells were also treated with IFN-γ and expression of 
STAT1α detected (Adapted from 27). 
 
A peptide antagonist of SOCS-1 reduces HSV-1 induced CPE in HEL-30  
 
The role of SOCS-1 was established in inhibition of IFN-γ  antiviral activity. SOCS-1  
 
binds to JAK2 and prevents its phosphorylation.  Subsequently, they synthesized an  
 
antagonist of SOCS-1 which binds to the kinase inhibitory region (KIR) of SOCS-1 and  
 
prevents the binding of SOCS-1 to JAK2.  Therefore JAK2 phosphorylates STAT1α and  
 
IFN-γ signaling pathway will be continued. HEL-30 cells were cultured and then treated  
 
with IFN-γ . Different concentration of pJAK2 added to HEL-30 cultures and then cells  
 
were infected with HSV-1. As shown in Figure 16 HEL-30 cells treated with  
 
35µM pJAK2 were completely survived from HSV-1 infection. HEL-30 cell survival  
 
dropped to 75% and 25%  with 17 and 8 µM concentration of  pJAK2, respectively (27). 
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Figure 16. Using a peptide antagonist of SOCS-1 in HSV-1 infected HEL-30 cells. HEL-30cells were 
treated with IFN-γ alone, or different concentrations of pJAK2 with or without 100U/ml of IFN-γ. Then 
cells were infected with HSV-1 and HSV-1 induced CPE monitored (Adapted from 27). 
 
Over expression of SOCS-1 inhibits the anti-viral activity of IFN-γ in HSV-1 
infected L929 cells 
       Expression of SOCS-1α significantly decreased the antiviral activity of IFN-γ in 
HEL-30 keratinocytes cells infected with HSV-1. This suggests overexpression of SOCS-
1α may have the same effect in the L929 cell lines. Therefore, a tyrosine kinase inhibitor 
peptide (Tkip) (a SOCS-1 mimetic peptide) was developed. This small peptide 
(WLVFFVIFYFFR) and Tkip2 (alanine was substituted with phenylalanine) was used to 
transfect fibroblasts which were treated with IFN-γ and infected with HSV-1. L929 
fibroblasts were cultured and then were transfected with control plasmid or pFLAG-
SOCS -1 plasmid. Cells then treated with IFN-γ and after 24 hours cells were infected 
with HSV-1. Tkip prevented antiviral activity in fibroblast in the same manner as SOCS-
1did in keratinocytes. In contrast Tkip2 did not show any effect on IFN-γ antiviral 
HSV-1          - - +    +    +    +    +    +    +     + 
IFNγ - - - +    - +    - +    - +
pJAK2, µM - 35   - - 35  35   17  17    8    8 
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activity (27). Therefore using SOCS-1 peptide antagonist could have some benefits in 
persons infected with HSV-1 infection. 
 
 
Figure 17. Overexpression of SOCS-1 in L929 cells inhibited IFN-γ anti viral activity. L929 fibroblasts 
transfected with the indicated amounts of control plasmid or pFLAG-SOCS plasmid. Then cells treated 
with 100 U/ml IFN/γ for 24 hours. Cells infected with HSV-1. HSV-1 induced CPE was measured 
(Adapted from 27). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Control plasmid, µg    0           2            0           0
SOCS-1 plasmid, µg    0           0            1           2
IFNγ − +            +           +
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 Discussion 
            Herpes simplex virus 1 infection induces innate and adaptive immune responses (9). 
NK cells and macrophages play an important role in clearing viruses from the body in the 
first hours of the virus attack.  In the innate response, proinflammatory cytokines such as 
TNF-α, IFN type I (α&β) are involved (9). Nitric oxide (NO) produced by macrophages 
also may act directly against HSV-1 in early HSV-1 infection.  If innate immunity cannot 
clear the virus from the body, adaptive immunity needs to be activated (9).  
        Cell mediated immunity, especially involving CD8+ T cells and CD4+ T cells, is 
important in adaptive immunity (1, 7).  Like other viruses HSV-1 replication takes place 
in the cells. CD8+ T cells are able to destroy the cell infected with HSV-1 by cytotoxic 
effect (6). After primary infection, HSV-1 moves to the neuronal cells and is retained in a 
latent state. One reason why neuronal cells could be selected by the virus for replication 
is the low level expression of MHC molecules (1). Transient expression of MHC class I 
molecules on neuronal cells would induce CD8+ T cells to take action against HSV-1 (1).  
         Expression of HSV-1 immediate early genes such as ICP0, ICP4, and ICP27 
induces early and late gene products, which finally leads to virus replication (7).  
Expression or absence of ICP0, ICP4, ICP27 and LAT proteins has a pivotal role in virus 
latency. Low level expression of α and β genes are essential for induction of immune 
response against HSV-1 (7).  
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        CD8+ T cells produce IFN-γ to keep HSV-1 in a latent state without any cell 
destruction (1). Suvas et al. (1) showed co-expression of CD94-NKG2a on CD8+ T cells 
and interaction with Qa-1
b
 molecule on neuronal cells that prevent the neuronal cell 
destruction by CD8+ T cells. They showed the majority of Ag-specific CD8+ T cells 
express NKG2a (65%) and CD94 molecules.  MC-38 cells (a colon carcinoma cell line) 
as target cells were examined for Qa-1
b 
molecule expression and 50% of these cells were 
able to express Qa-1
b 
molecule (1).   
           An immunogenic peptide derived from HSV-1 (SSIEFAR) was added in two 
different concentrations (2.0 and 0.2 µM) to target cells that were co-cultured with CD8+ 
T cells.  This system was used to determine the level of cytotoxicity of CD8+T cells for 
the HSV-1 peptide.  Both concentrations showed significant cell lysis in the presence of 
the CD8 +T cells. Blocking of the CD94-NKG2a-Qa1
b
 interaction led to increased CPE 
of target cells. These results demonstrated that, in spite of expression of lytic granules in 
HSV-specific CD8+Tcells for the treated carcinoma cell line, these CD8+ T cells could 
not destroy the cultured neuronal cells due to CD94-NKG2a-Qa1
b
 interaction. This 
interaction inhibits CD8+ T cell cytotoxicity and keeps HSV-1 in latency (1).  
         CD94 molecule expression on CD8+ T cells could be induced by TGF-β1 present in 
TG (1). Depletion of CD4+ CD25+ cells resulted in severe disease in mice infected with 
HSV-1 and also reduction of the percentage of TGF-β1 produced (1). Thus CD4+CD25+ 
cells have a pivotal role in CD8+ T cell cytotoxicity.  Although mice were depleted 
>90% from CD4+CD25+ T cells, the small remaining (4%) Foxp3 CD4+ cells in TG 
may induce TGF-β1 expression. Therefore Foxp3 CD4+ cells may serve as another 
source of TGF-β1 (1).   
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         Lymphocytes with cytokine production persist in TG to maintain HSV-1 in latency. 
Halford et al. (7) showed that cytokine transcript expression (especially IL-10 and IFN-γ 
mRNAs) was strongly up-regulated in TG 5 days post inoculation in ICR mice (7). 
Cytokines IL-2, IL-10, IFN-γ, RANTES, and TNF-α mRNAs were detected in TG 14, 
24, 35, 60 and 125 days p.i. by using RT-PCR analysis (7). 
        The HSV-1infection also was confirmed by detection of ICP27 gene expression. 
ICP27 mRNA was not detected, but LAT RNA was expressed in TG, showing that virus 
was in a non-replicating state. Thus lymphocytes with production of cytokines have 
important role to maintain HSV-1 in latent state and prevent the reactivation of the virus 
in TG (7). 
        Expression of cytokines expression such as TNF-α, IL-6, and IFN-γ  inhibits HSV-1 
reactivation in TG. TNF-α is also produced in the innate response against HSV-1 by 
macrophages and NK cell (8).  Minagawa and colleagues (8) examined the efficacy of 
TNF-α depletion in HSV-1 reactivation both in TG culture, and in TNF-knockout mice. 
They showed depletion of TNF-α in cell culture infected with HSV-1 increased virus 
reactivation. In the in vivo experiment, the survival of TNF-KO mice infected with HSV-
1 dropped to 0% to 40%. Therefore this study confirmed that TNF- α also plays a pivotal 
role to inhibit HSV-1 reactivation in TG (8). 
         Neutrophils also participate indirectly in the immune defense against HSV-1 
infection.  Molesworth-Kenyan and associates (12) demonstrated that the survival 
percentage of BALB/c mice depleted of neutrophils significantly dropped. The number of 
CD8+ T cells, CD4+ Tcells, neutrophils, and CXCR3+ expressing cells in DTH 
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decreased in neutrophil depleted mice.  They also showed neutrophil depletion decreased 
the production of IP-10 and Mig in delayed type hypersensivity (DTH) (12). 
          Viruses employ tactics to escape from the host immune defense, for example 
expression of virulence factor B8R by vaccinia virus impedes IFN-γ antiviral activity. 
This protein binds to IFN-γ and inhibits its binding to the cell surface receptor. Ahmed 
and colleagues (18) showed that a synthesized IFN-γ peptide mimetic bound to the 
intracellular domain of IFNGR1 and induced phosphorylation of JAK/STAT mediators 
and blocked the B8R activity.  They treated C57BL/6 mice with different doses of mIFN-
γ 95-132, and then challenged with vaccinia virus with B8R production potential. Results 
showed most mice were protected from death (18).  
       This approach led the investigators to design an IFN-γ mimetic peptide therapy for 
the persons infected with vaccinia virus and other viruses. This finding may be useful in 
clinical therapy to protect persons against diseases caused by vaccinia and other viruses 
such as HSV-1(18).   
        IFN-γ produced by CD8+ T cells induces gene activation through internalization to 
the cell by a specific signaling pathway. This pathway is initiated by binding of IFN-γ to 
its specific receptor IFNGR1/IFNGR2. IFN-γ interaction with IFNGR1 leads to 
JAK/STAT phosphorylation and finally activation of other signal mediators. This signal 
will be transferred to the nucleus to initiate the GAS activation. IFN-γ NLS domain has 
an important role in IFN-γ signaling pathway. IFN-γ  and IFN-γ mimetic interact with 
IMPα5 in cytosol through complex of IFN-γ-IFNGR1/phoshorylated STAT1α (22). 
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         Fulcher et al. (22) showed that the IFN-γ mimetic peptide has the same affinity for 
IMPs as does IFN-γ in signal transduction to the nucleus. Using ELISA- based binding 
assay they showed that both IFN-γ and mIFN-γ had affinity to IMPs (antibody specific to 
IMPα-GST). They also explained mIFN-γ peptide mimetic was more active than IFN-γ in 
activating the GAS promoter (by measuring of lucifrase activity). These results 
demonstrated that high affinity of IMPα/β for mIFN-γ mimetic leads to more activation 
of GAS promoter and gene activation. Thus IFN-γ mimetic peptide could be used in 
future studies in place of IFN-γ (22). 
         Suppressor of cytokine signaling (SOCS) is a strategy employed by HSV-1 to 
escape from immune system. SOCS binds to JAK2 autophosphorylation site via SOCS-
KIR (kinase inhibitor region). This binding prevents auto phosphorylation of STAT1α 
and inhibits signal transduction. Abnormal phosphorylation of tyrosine region of kinases 
causes some diseases, for example experimental allergic encephalomyelitis (EAE). Tkip 
or SOCS mimetic peptide could have some benefits in protection of mice from EAE (21). 
          Mujtaba and colleagues (21) developed a tyrosine kinase inhibitory peptide (Tkip) 
which has 12 residues (WLVFFVIFYIFYFFR) which binds to the tyrosine kinase residue 
of JAK2 and makes it inaccessible for binding of STAT1α. They showed Tkip-treated 
mice survived acute EAE. Therefore using Tkip could be useful to control inflammatory 
diseases such as EAE (21). 
           SOCS-1 is used by HSV-1 to escape from body’s immune system. Similar to Tkip, 
SOCS-1 KIR recognizes the JAK2 tyrosine region for its function. Waiboci and 
associates (23) demonstrated both SOCS-1-KIR and Tkip bind to JAK2 
autophosphorylation site and prevent binding and autophosphorylation of STAT1a (21). 
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         Binding assay showed both SOCS1-KIR and Tkip bound to JAK2 
autophosphorylation site. Macrophages have a key role in anti viral resistance, and are 
inducible by IFN-γ. They used macrophage cell line Raw 264.7 which was activated by 
IFN-γ and SOCS1-KIR or Tkip were then used to determine if they are able to block NO 
production by macrophages.  Both Tkip and SOCS1-KIR inhibited the NO production. 
Thus SOCS1 antagonist may provide a therapeutic strategy to inhibit virus replication by 
prevention of SOCS1 function (23). 
         Using SOCS3 Yokota and colleagues (24) demonstrated that IFN-α signal 
transduction pathway was blocked in JAK phosphorylation site in the same manner as 
SOCS-1. They also showed overexpression of SOCS3 in FL cell culture had the same 
result. Western blot showed STAT1 phosphrylation was inhibited in SOCS3 over 
expressed cells. These results determined HSV-1 uses SOCS3 in the same strategies as 
SOCS1 for its anti viral function (24). 
        Keratinocyte cells are the most important site for HSV-1 replication. The SOCS 
family expression (SOCS1, SOCS2, SOCS5, and CIS) was highly increased in IFN-γ 
infected keratinocytes. Frey et al. (27) showed IFN-γ inhibited the HSV-I infection in 
fibroblasts but did not prevent the viral replication in keratinocytes. This is because of 
SOCS-1 expression in keratinocytes cells but not in fibroblasts.  Using SOCS-1 peptide 
antagonist in keratinocytes increased the percentage of cell survival. In the other hand 
overexpression of SOCS-1 in fibroblasts treated with IFN-γ  and later infected with HSV-
1 decreased the fibroblast survival (27). 
         Although SOCS proteins have important role in inhibition of body’s anti viral 
defense, it is not the only strategy employed by HSV-1. Rongtuanlin and colleagues (29) 
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have demonstrated   that other strategies can be used by HSV-1 to defeat body antiviral 
defense, which is not IFN-γ dependent. They have shown that the HSV-1 immediate early 
proteins ICP0 and virus shut off protein (vhs) together act against immune response (29).  
Therefore, further studies are needed to verify which of these strategies are more 
effective to block host immune response by HSV-1. This could be considered one 
limitation on this approach and would be an appropriate subject for future studies.  
         Based on this study regarding the effect of IFN-γ and SOCS-1 role on HSV-1 
reactivation and infection,  I suggest using an appropriate mouse model such as the 
corneal infection model of Frye and colleagues (30) in BALB/c or C3H mouse strains,  
both of which are sensitive to HSV-1 infection . Keratinocyte and fibroblast cell cultures 
of these strains were used by Frey and colleagues to show the efficacy of the IFN-γ 
mimetic and SOCS-1 antagonist in inhibiting the cyptopathic effect of HSV-1, strain 
17syn+ (27) in mouse keratinocytes.  In my proposed experiment, both IFN-γ peptide 
mimetic and SOCS-1 antagonist would be used as a drug therapy to reduce the number 
 of corneal lesions by 3-4 days after HSV-1 reactivation  (31).  In this experiment, mice 
will be exposed to thermal stress (held for 10 minutes in a water-bath at 43 ° C)  28 days 
after initial corneal infection (31)  and  subsequently, their corneas will be examine daily 
for 5 days for the number of lesions. At the same time thermal stress is induced, the mice 
will be administered (by oral or intraperitoneal route) SOCS-1 antagonist and INN-γ 
peptide mimetic. This treatment will be repeated on day 2 and 4 after induction of 
thermal stress. The mice will be examined daily for 5 days for the number of ocular 
lesions. It is expected that reduced numbers of ocular leasions will be seen in comparison  
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with control mice that had received thermal stress but no treatments. If so, the experiment 
will be repeated and the trigeminal neurons will be removed from the mice in each of 
these groups and examined immunohistochemically for the presence of phosphorylated 
JAK2. This observation would confirm the cell culture observations of the molecular 
events in which the IFN-γ peptide mimetic induces antiviral activity through binding to 
intracellular domain of IFNGR1, and subsequently initiates autophosphorylation of 
JAK2/STAT1α pathway (18, 19, And 20). In addition, SOCS-1 antagonist binds to KIR 
region of SOCS-1 produced by virus and inhibits its activity.  
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